- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancer, Bladder in Hong Kong
Total 1041 results
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Novartis PharmaceuticalsCompleted
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
Shanghai Henlius BiotechRecruitingLimited-Stage Small Cell Lung CancerUnited States, China, Greece, Spain, Austria, Czechia, Germany, Hungary, Latvia, Netherlands, Poland
-
MacroGenicsCompletedCervical Cancer | Hematologic Neoplasms | Ovarian Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Small-cell Lung Cancer | TNBC - Triple-Negative Breast Cancer | HER2-positive Advanced Solid TumorsHong Kong, United States, Thailand, Australia, Spain, Bulgaria, Poland, Ukraine
-
NovartisProcter and GambleCompletedUrinary IncontinenceUnited States
-
Targacept Inc.CompletedOveractive BladderUnited States
-
BeiGeneActive, not recruitingRecurrent or Metastatic Nasopharyngeal CancerChina, Taiwan, Thailand
-
National Institute of Mental Health (NIMH)Completed
-
Urovant Sciences GmbHCompleted
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Hoffmann-La RocheCompletedGastric CancerHong Kong, Colombia, Russian Federation, Peru, Korea, Republic of, China, Mexico, Brazil, Argentina, Guatemala, Uruguay, Malaysia, Belize, Panama
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedStage IA Uterine Corpus Cancer AJCC v7 | Stage IB Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus... and other conditionsUnited States, Canada, Hong Kong
-
National Cancer Center, KoreaTerminatedBreast Cancer | Metastatic DiseaseKorea, Republic of
-
Samsung Medical CenterNational Cancer Center, KoreaCompletedProstatic CancerKorea, Republic of
-
PfizerCompletedOveractive BladderUnited States
-
Novartis PharmaceuticalsTerminated
-
OPKO Health, Inc.CompletedBreast Cancer | Bone Neoplasms | Prostate Cancer | Hypocalcemia | Hyperparathyroidism, SecondaryUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminatedLung CancerUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
Institut de Recherche pour le DeveloppementNational Cancer Institute, France; Fondation de FranceCompletedHPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study (PapilloV)Cervical CancerThailand
-
Rutgers, The State University of New JerseyRecruitingCardiac Toxicity | Early-stage Breast CancerUnited States
-
MediciNovaCompletedInterstitial CystitisUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary IncontinenceUnited States
-
National Cancer Institute (NCI)RecruitingStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 | Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Myriad Genetic Laboratories, Inc.Recruiting
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingAdvanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Canada, Australia, Hong Kong, Korea, Republic of
-
Translational Oncology Research InternationalCompletedAcinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Xoft, Inc.TerminatedBreast CancerUnited States
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Aristotle University Of ThessalonikiNot yet recruitingMedullary Thyroid CancerChina, Switzerland, Spain, Greece, United States, Austria, Belgium, Brazil, Bulgaria, Colombia, Croatia, France, India, Iraq, Italy, Jordan, Morocco, Poland, Serbia, Slovakia, Thailand, Turkey, Ukraine, Vietnam
-
Spectrum Pharmaceuticals, IncActive, not recruitingBreast Cancer | NeutropeniaUnited States
-
Taiho Oncology, Inc.CompletedBreast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR TumorsFrance, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
-
HUYABIO International, LLC.RecruitingCancer | Colorectal Cancer | Lung Cancer | Solid Tumor | Non Small Cell Lung Cancer | Colon Cancer | Cancer of PancreasUnited States, Puerto Rico
-
RAPT Therapeutics, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced CancerHong Kong, United States, Australia, Korea, Republic of, Taiwan, Thailand
-
OncotechUnknown
-
Urovant Sciences GmbHActive, not recruitingOveractive BladderUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustralia, Belgium, France, Italy, Hong Kong, Canada, Denmark, Taiwan, Russian Federation, United Kingdom, Spain, Hungary, Czech Republic, Poland, Germany, Netherlands
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Novartis PharmaceuticalsRecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | KRAS G12C Mutant Solid Tumors | Carcinoma, ColorectalUnited States, Japan, Australia, Germany, Italy, Spain, Canada, Denmark, Korea, Republic of, Taiwan, Belgium, Hong Kong, China, France, Singapore, Netherlands
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Translational Oncology Research InternationalGenentech, Inc.CompletedColorectal CancerUnited States
-
BioAtla, Inc.RecruitingNon-Small-Cell Lung CancerUnited States, Hong Kong, Taiwan, Spain, Greece, Germany, Italy, Poland
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine